160 related articles for article (PubMed ID: 27911853)
1. Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model.
Mehta FF; Baik S; Chung SH
Oncotarget; 2017 Jan; 8(2):2372-2380. PubMed ID: 27911853
[TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model.
Baik S; Mehta FF; Chung SH
Am J Pathol; 2019 Dec; 189(12):2459-2468. PubMed ID: 31732107
[TBL] [Abstract][Full Text] [Related]
3. Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
Chung SH; Wiedmeyer K; Shai A; Korach KS; Lambert PF
Cancer Res; 2008 Dec; 68(23):9928-34. PubMed ID: 19047174
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Inhibits Epithelial Progesterone Receptor-Dependent Progestin Therapy Efficacy in a Mouse Model of Cervical Cancer.
Baik S; Mehta FF; Unsal E; Park Y; Chung SH
Am J Pathol; 2022 Feb; 192(2):353-360. PubMed ID: 34774516
[TBL] [Abstract][Full Text] [Related]
5. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer.
Brake T; Connor JP; Petereit DG; Lambert PF
Cancer Res; 2003 Dec; 63(23):8173-80. PubMed ID: 14678972
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
10. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
11. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
[TBL] [Abstract][Full Text] [Related]
12. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
13. Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.
Son J; Park JW; Lambert PF; Chung SH
Carcinogenesis; 2014 Feb; 35(2):489-96. PubMed ID: 24148821
[TBL] [Abstract][Full Text] [Related]
14. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
15. TLR9 expression in uterine cervical lesions of Uyghur women correlate with cervical cancer progression and selective silencing of human papillomavirus 16 E6 and E7 oncoproteins in vitro.
Hao Y; Yuan JL; Abudula A; Hasimu A; Kadeer N; Guo X
Asian Pac J Cancer Prev; 2014; 15(14):5867-72. PubMed ID: 25081715
[TBL] [Abstract][Full Text] [Related]
16. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy.
Spurgeon ME; Chung SH; Lambert PF
Am J Pathol; 2014 Feb; 184(2):530-40. PubMed ID: 24418098
[TBL] [Abstract][Full Text] [Related]
18. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
19. Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.
Magaldi TG; Almstead LL; Bellone S; Prevatt EG; Santin AD; DiMaio D
Virology; 2012 Jan; 422(1):114-24. PubMed ID: 22056390
[TBL] [Abstract][Full Text] [Related]
20. Dominant role of HPV16 E7 in anal carcinogenesis.
Thomas MK; Pitot HC; Liem A; Lambert PF
Virology; 2011 Dec; 421(2):114-8. PubMed ID: 21999991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]